Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase - PubMed (original) (raw)
. 1993 Jun 15;268(17):12837-42.
Affiliations
- PMID: 8099586
Free article
Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase
K Carroll et al. J Biol Chem. 1993.
Free article
Abstract
Deletion of the vaccinia virus K3L gene, a homologue of the alpha subunit of protein synthesis initiation factor 2, has been reported to reduce the ability of the virus to grow in interferon-treated cells (Beattie, E., Tattaglia, J., and Paoletti, E. (1991) Virology 183, 419-422). Purified recombinant K3L gene product, pK3r, has potent effects on activation of double-stranded (ds) RNA-dependent, initiation factor-2 alpha (eIF-2 alpha)-specific protein kinase (PKR) in in vitro reactions. Recombinant pK3 prevents the inhibition of protein synthesis by dsRNA in a cell-free translation system from rabbit reticulocytes at levels equal to, or lower than, the level of endogenous eIF-2 alpha. In the cell-free translation system, pK3r exerts its effects at all dsRNA concentrations tested, by preventing phosphorylation of eIF-2 alpha. In addition, pK3r reduces the autophosphorylation of immunopurified PKR, as well as its ability to phosphorylate the alpha subunit of purified eIF-2. At 400 mM NaCl, in vitro translated [35S]methionine-radiolabeled pK3 can be co-immunoprecipitated with human PKR, using a monoclonal antibody to PKR. This tight binding is consistent with a role for pK3 as a pseudosubstrate for the kinase, and identifies the amino-terminal 30% of eIF-2 alpha as the domain recognized by the eIF-2 alpha-specific protein kinases. In addition, the tight binding opens up the possibility of using binding assays to identify functional domains within the kinase and pK3. Recombinant pK3 also prevents activation of the heme-sensitive eIF-2 alpha-specific protein kinase, eIF-2 alpha-PKh, in both cell-free translation systems as well as in partially purified preparations. This suggests some similarity between the eIF-2 alpha binding domains of the two eIF-2 alpha specific protein kinases.
Similar articles
- The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms.
Davies MV, Chang HW, Jacobs BL, Kaufman RJ. Davies MV, et al. J Virol. 1993 Mar;67(3):1688-92. doi: 10.1128/JVI.67.3.1688-1692.1993. J Virol. 1993. PMID: 8094759 Free PMC article. - The phosphorylation of eukaryotic initiation factor 2: a principle of translational control in mammalian cells.
Sarre TF. Sarre TF. Biosystems. 1989;22(4):311-25. doi: 10.1016/0303-2647(89)90053-1. Biosystems. 1989. PMID: 2679904 Review. - Proteins that interact with PKR.
Jagus R, Gray MM. Jagus R, et al. Biochimie. 1994;76(8):779-91. doi: 10.1016/0300-9084(94)90082-5. Biochimie. 1994. PMID: 7893827 Review.
Cited by
- Systematic genetic characterization of the human PKR kinase domain highlights its functional malleability to escape a poxvirus substrate mimic.
Chambers MJ, Scobell SB, Sadhu MJ. Chambers MJ, et al. bioRxiv [Preprint]. 2024 Sep 22:2024.05.29.596416. doi: 10.1101/2024.05.29.596416. bioRxiv. 2024. PMID: 38903081 Free PMC article. Preprint. - Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer.
Nia GE, Nikpayam E, Farrokhi M, Bolhassani A, Meuwissen R. Nia GE, et al. Mol Ther Oncol. 2024 Feb 29;32(1):200788. doi: 10.1016/j.omton.2024.200788. eCollection 2024 Mar 21. Mol Ther Oncol. 2024. PMID: 38596310 Free PMC article. Review. - Systematic characterization of the local evolutionary space available to human PKR and vaccinia virus K3.
Chambers MJ, Scobell S, Sadhu MJ. Chambers MJ, et al. bioRxiv [Preprint]. 2023 Nov 22:2023.11.21.568178. doi: 10.1101/2023.11.21.568178. bioRxiv. 2023. PMID: 38076952 Free PMC article. Preprint. - How to Inhibit Nuclear Factor-Kappa B Signaling: Lessons from Poxviruses.
Reus JB, Rex EA, Gammon DB. Reus JB, et al. Pathogens. 2022 Sep 18;11(9):1061. doi: 10.3390/pathogens11091061. Pathogens. 2022. PMID: 36145493 Free PMC article. Review. - Small Hero with Great Powers: Vaccinia Virus E3 Protein and Evasion of the Type I IFN Response.
Szczerba M, Subramanian S, Trainor K, McCaughan M, Kibler KV, Jacobs BL. Szczerba M, et al. Biomedicines. 2022 Jan 22;10(2):235. doi: 10.3390/biomedicines10020235. Biomedicines. 2022. PMID: 35203445 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous